RxDoctor Payments Data

Crystal Frutchey, PA

Physician Assistant · Pineurst, NCNPI 1366982944

Payments from drug & device makers

$2,290in general payments, 2019–2025

Across 163 payments — averaging $14.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$695
  • Lilly USA, LLC$543
  • AbbVie$448
  • Exact Sciences$209
  • Bayer$85
  • Amgen$69
  • plus $241 from 10 others

What the payments were for

  • Food & beverage$2,290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,290 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$54,441
Medicare patients
125
Services billed
1,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide103$118,877
OzempicSemaglutide74$87,401
JardianceEmpagliflozin42$36,920
FarxigaDapagliflozin Propanediol16$17,450
MyrbetriqMirabegron31$16,260
EliquisApixaban11$9,325
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,820
Tresiba Flextouch U-100Insulin Degludec14$6,778
Tresiba Flextouch U-200Insulin Degludec11$6,238
SymbicortBudesonide/Formoterol Fumarate15$5,318
Rosuvastatin Calcium183$1,949
Atorvastatin Calcium184$1,545
Amlodipine Besylate142$1,159
Albuterol Sulfate HfaAlbuterol Sulfate33$1,109
Bupropion XlBupropion Hcl35$1,070

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$543$118,877103 claims
Novo NordiskOzempic$695$87,40174 claims
Boehringer IngelheimJardiance$20$36,92042 claims
AstraZenecaFarxiga, Symbicort$47$22,76831 claims
Astellas Pharma US IncMyrbetriq$43$16,26031 claims
PfizerEliquis$20$9,32511 claims
GSKTrelegy Ellipta$17$7,82012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Pineurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →